The first JSE-listed company to have links to the fast-growing cannabis industry, estimated to be as large as R27bn, Labat Africa has made a number of acquisitions to help it in its new venture. It dumped its fuel interests recently and expects cannabis to make up almost all of its revenue by 2021. Labat Pharmaceuticals CEO Mike Stringer talks to Business Day about the technical aspects of the industry and its plans to expand into the cannabis market.

What regulatory environment does Labat Africa find itself in, and how are you planning to navigate the move into cannabis? 

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now